Companies › HIMS

HIMS & HERS HEALTH INC (HIMS)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001773751 · EDGAR filings · Updated 2026-07-28

HIMS & HERS HEALTH INC (HIMS) has reported institutional ownership of 65.4%, with 432 institutional managers holding positions valued at $3.09B per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), substantial-doubt (going concern) disclosure per the filings.

Filings this week (2)

• 2026-07-28 — SCHEDULE 13G/A filed
• 2026-07-22 — Notice of proposed sale filed (Form 144)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-20 — Insider transaction reported (Form 4)
• 2026-07-17 — Current report (8-K) filed
• 2026-07-07 — Insider transaction reported (Form 4)
• 2026-07-06 — Notice of proposed sale filed (Form 144)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, HIMS & HERS HEALTH INC has 432 institutional holders and institutional ownership of 65.4%.

Insider activity

Insiders reported 283 transactions (0 buys, 133 sells) across 15 reporting insiders, with a net reported value of −$148.3M.

Data flags from SEC filings

Related companies

IDEAYA BIOSCIENCES INC (IDYA) · ARCUTIS BIOTHERAPEUTICS INC (ARQT) · ACADIA HEALTHCARE COMPANY IN (ACHC) · TRAVERE THERAPEUTICS INC (TVTX) · SUPERNUS PHARMACEUTICALS (SUPN) · VERACYTE INC (VCYT)